| Financial Year |
March 31 2023 |
| Monetary Funds |
1,243,026,529.27 |
| Held-for-trading Financial Assets |
483,853,082.08 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,055,771,154.08 |
| Advances to Suppliers |
3,416,322.38 |
| Other Receivables |
3,899,709.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
702,559,609.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
600,099.86 |
| Total Current Assets |
4,167,076,667.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
13,413,324.53 |
| Fixed Assetes |
1,173,271,728.38 |
| Under-construction Projects |
105,338,739.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
120,108,825.22 |
| R&D expenses |
-- |
| Goodwill |
19,154,867.23 |
| Long-Term Deferred and Prepaid Expenses |
43,657,417.19 |
| Deferred Income Tax Assets |
321,609.91 |
| Other Non-Current Assets |
130,742,296.19 |
| Sub-Total of Non-Current Assets |
1,609,647,635.95 |
| Total Assets |
5,776,724,303.22 |
| Short-Term Loans |
18,617,768.81 |
| Trading Financial liabilities |
9,333,235.93 |
| Notes Payable |
737,960,792.45 |
| Accounts Payable |
309,007,662.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
67,699,490.84 |
| Taxes Payable |
69,773,226.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,606,325.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
340,926.73 |
| Other Current Liabilities |
443,872.02 |
| Sub-Total of Current Liabilities |
1,234,943,025.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
114,350,178.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
170,182,913.42 |
| Total Liabilities |
1,405,125,938.79 |
| Paid-In Capital(Or Share Stock) |
225,000,000.00 |
| Capital Surplus |
261,968,788.03 |
| Surplus Reserve |
157,125,187.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,668,481,939.14 |
| Minority Stockholder's Interest |
61,594,949.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,310,003,414.61 |
| Owner's Equity（Stockholder's Equity） |
4,371,598,364.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,776,724,303.22 |
